GlassScriptPhysician profile
Marietta Grace Young
NPI 1871122580
$2,060.44
in general payments reported to CMS, 2019-2025
25 companies · $1,292 in 2025
The $1,292 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.48 · 2021: $153 · 2022: $115 · 2024: $489 · 2025: $1,292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,781.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $233.27 | 2022-2025 | Jardiance |
| Novo Nordisk INC | $181.85 | 2020-2025 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $153.84 | 2021-2025 | Wainua |
| Regeneron Healthcare Solutions, INC. | $151.49 | 2025 | Evkeeza |
| Philips North America LLC | $131.00 | 2025 | Lm Undivided |
| Abiomed | $122.43 | 2025 | |
| Heartflow, INC. | $120.77 | 2024 | |
| Novartis Pharmaceuticals Corporation | $114.60 | 2024-2025 | |
| Idorsia Pharmaceuticals US INC | $108.16 | 2025 | Tryvio |
| Pfizer INC. | $94.99 | 2024-2025 | |
| Alnylam Pharmaceuticals INC. | $90.75 | 2025 | Amvuttra |
| Inspire Medical Systems, INC. | $87.39 | 2024-2025 | Inspire |
| E.R. Squibb & Sons, L.L.C. | $69.04 | 2024-2025 | Camzyos, Eliquis |
| Bridgebio Pharma, INC. | $66.26 | 2025 | Attruby |
| Janssen Pharmaceuticals, INC | $55.38 | 2021-2024 | Xarelto |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $55.04 | 2025 | Verquvo |
| United Therapeutics Corporation | $50.44 | 2024-2025 | Tyvaso, Tyvaso |
| Procyrion, INC. | $41.05 | 2025 | Aortix System |
| Alexion Pharmaceuticals, INC. | $25.03 | 2022 | |
| Boston Scientific Corporation | $21.97 | 2024 | Latitude Communicator Power Supply |
| Bayer Healthcare Pharmaceuticals INC. | $19.47 | 2025 | |
| Ge Healthcare | $18.95 | 2025 | |
| Irhythm Technologies, INC. | $16.96 | 2024 | Zio Xt Patch, Zio Monitor |
| Kiniksa Pharmaceuticals International, Plc | $16.68 | 2024 | Arcalyst |
| Chiesi USA, INC. | $13.63 | 2024 | Juxtapid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marietta Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.